Search - tctmd.com

Displaying 201 - 220 of 4251

Sort: Relevancy | Date

Presentation TCT 2016

Severe AS and Chronic Kidney Disease

Presenter: Howard C. Herrmann, Vinod H. Thourani, Molly Szerlip

October 31, 2016

Presentation TCT 2016

Severe AS and COPD

Presenter: Howard C. Herrmann, Vinod H. Thourani, Kendra J. Grubb

October 31, 2016

Presentation TCT 2016

Low-gradient AS Diagnosis and Management

Presenter: Howard C. Herrmann, Vinod H. Thourani, Allan Schwartz

October 31, 2016

Presentation TCT 2016

Severe AS With a Small Aortic Annulus

Presenter: Howard C. Herrmann, Vinod H. Thourani, Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, John D. Carroll

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Helene Eltchaninoff

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Neil E. Moat

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Thomas Walther

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti

October 30, 2016

Presentation TCT 2016

Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation (Aortic and Mitral)

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Rebecca T. Hahn

October 30, 2016

Presentation TCT 2016

Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative?

Presenter: A. Pieter Kappetein, Allan Schwartz, Hendrik Treede

October 30, 2016

Presentation TCT 2016

Comments and What I Might Have Done Differently

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Jose Armando Mangione

October 30, 2016

Presentation TCT 2016

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager

October 30, 2016

Advertisement

Severe AS and Chronic Kidney Disease

Severe AS and COPD

Low-gradient AS Diagnosis and Management

Severe AS With a Small Aortic Annulus

Severe AS and LV Dysfunction

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation (Aortic and Mitral)

Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative?

Comments and What I Might Have Done Differently

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content